BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31856435)

  • 1. [An interlaboratory comparison study on the detection of RUNX1-RUNX1T1 fusion transcript levels and WT1 transcript levels].
    Qin YZ; Zhu LW; Lin S; Geng SX; Liu SW; Cheng H; Wu CY; Xiao M; Li XQ; Hu RP; Wang LL; Liu HY; Ma DX; Guan T; Ye YX; Niu T; Cen JN; Lu LS; Sun L; Yang TH; Wang YG; Li T; Wang Y; Li QH; Zhao XS; Li LD; Chen WM; Long LY; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2019 Nov; 40(11):889-894. PubMed ID: 31856435
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prognostic value of dynamic monitoring of RUNX1-RUNX1T1 transcript in pediatric acute myeloid leukemia].
    Gao HT; Zhang Y; Sun K; Guo JM; Chen YQ; Chen XL; Shi J; Niu XN; Wang F; Huo L
    Zhonghua Xue Ye Xue Za Zhi; 2017 Mar; 38(3):210-215. PubMed ID: 28395444
    [No Abstract]   [Full Text] [Related]  

  • 3. Low WT1 transcript levels at diagnosis predicted poor outcomes of acute myeloid leukemia patients with t(8;21) who received chemotherapy or allogeneic hematopoietic stem cell transplantation.
    Qin YZ; Wang Y; Zhu HH; Gale RP; Zhang MJ; Jiang Q; Jiang H; Xu LP; Chen H; Zhang XH; Liu YR; Lai YY; Jiang B; Liu KY; Huang XJ
    Chin J Cancer; 2016 May; 35():46. PubMed ID: 27197573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dynamics of RUNX1-RUNX1T1 transcript levels after allogeneic hematopoietic stem cell transplantation predict relapse in patients with t(8;21) acute myeloid leukemia.
    Qin YZ; Wang Y; Xu LP; Zhang XH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Chen Y; Mo XD; Zhao XS; Chang YJ; Liu KY; Huang XJ
    J Hematol Oncol; 2017 Feb; 10(1):44. PubMed ID: 28166825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A multicenter study on the validation of conversion factor for the conversion of BCR-ABL (P210) transcript levels to the international scale in chronic myeloid leukemia].
    Qin Y; Lin Z; Cen J; Li X; Li Q; Cheng H; Geng S; Wang Y; Ma D; Qiao C; Li J; Li L; Huang X
    Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):134-7. PubMed ID: 24606655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subgroup Analysis Can Optimize the Relapse-Prediction Cutoff Value for WT1 Expression After Allogeneic Hematologic Stem Cell Transplantation in Acute Myeloid Leukemia.
    Qin YZ; Wang Y; Xu LP; Zhang XH; Zhao XS; Liu KY; Huang XJ
    J Mol Diagn; 2020 Feb; 22(2):188-195. PubMed ID: 31751675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Related Factors Affecting Long-term Prognosis of AML Children with Positive RUNX1-RUNX1T1].
    Teng GY; Qu WJ; Zhang K
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Dec; 27(6):1767-1773. PubMed ID: 31839036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimal residual disease monitoring in t(8;21) acute myeloid leukemia based on RUNX1-RUNX1T1 fusion quantification on genomic DNA.
    Duployez N; Nibourel O; Marceau-Renaut A; Willekens C; Helevaut N; Caillault A; Villenet C; Celli-Lebras K; Boissel N; Jourdan E; Dombret H; Figeac M; Preudhomme C; Renneville A
    Am J Hematol; 2014 Jun; 89(6):610-5. PubMed ID: 24616160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent altered fusion transcript splicing identifies RUNX1-RUNX1T1+ AML patients likely to relapse.
    Ommen HB; Ostergaard M; Yan M; Braendstrup K; Zhang DE; Hokland P
    Eur J Haematol; 2010 Feb; 84(2):128-32. PubMed ID: 19891700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection and treatment of molecular relapse in acute myeloid leukemia with RUNX1 (AML1), CBFB, or MLL gene translocations: frequent quantitative monitoring of molecular markers in different compartments and correlation with WT1 gene expression.
    Doubek M; Palasek I; Pospisil Z; Borsky M; Klabusay M; Brychtova Y; Jurcek T; Jeziskova I; Krejci M; Dvorakova D; Mayer J
    Exp Hematol; 2009 Jun; 37(6):659-72. PubMed ID: 19463768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elucidation of Novel Therapeutic Targets for Acute Myeloid Leukemias with
    Yun JW; Bae YK; Cho SY; Koo H; Kim HJ; Nam DH; Kim SH; Chun S; Joo KM; Park WY
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30959925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of CD19 and CD56 in AML Patients with RUNX1-RUNX1T1 Mutation and Its Clinical Significance].
    Hu ZL; Zhang F; Huang BJ; Pan SJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun; 26(3):727-732. PubMed ID: 29950211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rare BCR-ABL1 transcript in a RUNX1-RUNX1T1-positive de novo acute myeloid leukemia: The chicken and egg tale.
    Gupta R; Mittal N; Rahman K; Sharma A; Singh P; Kumar S; Nityanand S
    Int J Lab Hematol; 2018 Apr; 40(2):e24-e27. PubMed ID: 29393574
    [No Abstract]   [Full Text] [Related]  

  • 14. Transcriptional dysregulation mediated by RUNX1-RUNX1T1 in normal human progenitor cells and in acute myeloid leukaemia.
    Tonks A; Pearn L; Musson M; Gilkes A; Mills KI; Burnett AK; Darley RL
    Leukemia; 2007 Dec; 21(12):2495-505. PubMed ID: 17898786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rearrangement of VPS13B, a causative gene of Cohen syndrome, in a case of RUNX1-RUNX1T1 leukemia with t(8;12;21).
    Abe A; Yamamoto Y; Katsumi A; Okamoto A; Tokuda M; Inaguma Y; Yamamoto K; Yanada M; Kanie T; Tomita A; Akatsuka Y; Okamoto M; Kameyama T; Mayeda A; Emi N
    Int J Hematol; 2018 Aug; 108(2):208-212. PubMed ID: 29264741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute myeloid leukemia with del(X)(p21) and cryptic RUNX1/RUNX1T1 from ins(8;21)(q22;q22q22) revealed by atypical FISH signals.
    Jang JH; Yoo EH; Kim HJ; Kim DH; Jung CW; Kim SH
    Ann Clin Lab Sci; 2010; 40(1):80-4. PubMed ID: 20124335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical Prognostic Factors Analysis of Initially Treated AML Children with t(8;21)/RUNX1-RUNX1T1
    Fan GL; Jiang PJ; Yuan M
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1510-1515. PubMed ID: 33067946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ubiquitin ligase STUB1 regulates stability and activity of RUNX1 and RUNX1-RUNX1T1.
    Yonezawa T; Takahashi H; Shikata S; Liu X; Tamura M; Asada S; Fukushima T; Fukuyama T; Tanaka Y; Sawasaki T; Kitamura T; Goyama S
    J Biol Chem; 2017 Jul; 292(30):12528-12541. PubMed ID: 28536267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A multicenter study on the revalidation of validated conversion factor for the conversion of BCRABL(P210)transcript levels to the international scale in chronic myeloid leukemia].
    Qin Y; Ma D; Wang Y; Wang L; Wang Y; Liu S; Lu X; Li X; Cen J; Xiao M; Lin Z; Geng S; Liang C; Chen H; Han C; Han W; Huang X
    Zhonghua Xue Ye Xue Za Zhi; 2015 Oct; 36(10):814-7. PubMed ID: 26477757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A multicenter comparison study on the quantitative detection of bcr-abl (P210) transcript levels in China].
    Qin YZ; Cheng H; Cen JN; Geng SX; Li QH; Li XQ; Lin ZX; Ma DX; Qiao C; Wang YG; Li JL; Li LD; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):104-8. PubMed ID: 23611214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.